Pediatrics
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Magnesium level | 692 |
| Uric acid level, blood | 697 |
| Test to determine lung volumes using sensors | 727 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 731 |
| Ferritin (blood protein) level | 763 |
| New patient office or other outpatient visit, 60-74 minutes | 765 |
| Blood glucose (sugar) test performed by hand-held instrument | 765 |
| Test to examine how well the lungs exchange gases | 771 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 782 |
| Telephone medical discussion with physician, 11-20 minutes | 794 |
| Administration and interpretation of patient-focused health risk assessment | 800 |
| Testing for presence of drug, by chemistry analyzers | 802 |
| Critical care, first 30-74 minutes | 820 |
| Dxa bone density measurement of hip, pelvis, spine | 830 |
| Iron level | 833 |
| Administration of vaccine | 834 |
| X-ray of part of lower jaw, 1-4 views | 840 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 856 |
| Single contrast x-ray of upper digestive tract | 867 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 887 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 927 |
| Administration and interpretation of caregiver-focused health risk assessment | 944 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 952 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 978 |
| Imaging for evaluation of swallowing function | 992 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 999 |
| X-ray of upper spine, 2-3 views | 1,017 |
| Adm sarscv2 bvl 30mcg/.3ml a | 1,064 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 1,071 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,083 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 1,093 |
| Test to measure expiratory airflow and volume | 1,102 |
| Destruction of precancer skin growth, 2-14 growths | 1,110 |
| Manual urinalysis test with examination using microscope, automated | 1,120 |
| Bacterial colony count, urine | 1,125 |
| Screening 3d breast mammography | 1,139 |
| Prostate cancer screening; prostate specific antigen test (psa) | 1,210 |
| Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 1,290 |
| Cyanocobalamin (vitamin b-12) level | 1,306 |
| Screening mammography | 1,316 |
| Assessment of emotional or behavioral problems | 1,397 |
| Therapy procedure using functional activities | 1,416 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 1,456 |
| Advance care planning, first 30 minutes | 1,586 |
| Emergency department visit with moderate level of medical decision making | 1,662 |
| Thyroxine (thyroid chemical), free | 1,708 |
| Annual alcohol misuse screening, 5 to 15 minutes | 1,730 |
| Vitamin d-3 level | 1,756 |
| Blood test, clotting time | 1,789 |
| Psa (prostate specific antigen) measurement, total | 1,809 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 1,873 |
| Test for allergy using skin patch | 1,978 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 2,156 |
| Hospital discharge day management, 30 minutes or less | 2,181 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 2,206 |
| Detection test by immunoassay with direct visual observation for influenza virus | 2,208 |
| Emergency department visit with high level of medical decision making | 2,295 |
| Urine microalbumin (protein) level | 2,297 |
| Established patient office or other outpatient visit, 10-19 minutes | 2,391 |
| Urinalysis, manual test | 2,469 |
| Administration of pneumococcal vaccine | 2,508 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 2,529 |
| Creatinine level to test for kidney function or muscle injury | 2,548 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 2,651 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 2,782 |
| Blood test, basic group of blood chemicals (calcium, total) | 2,829 |
| X-ray of chest, 2 views | 3,097 |
| Automated urinalysis test | 3,406 |
| New patient office or other outpatient visit, 30-44 minutes | 3,459 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 3,562 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 3,661 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 3,810 |
| Hospital discharge day management, more than 30 minutes | 4,331 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 4,413 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 4,425 |
| Professional service for single injection of allergen | 4,813 |
| Annual depression screening, 5 to 15 minutes | 4,814 |
| New patient office or other outpatient visit, 45-59 minutes | 5,249 |
| Blood test, thyroid stimulating hormone (tsh) | 5,693 |
| Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes | 6,432 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 6,562 |
| Injection of drug or substance under skin or into muscle | 7,318 |
| Test for allergy using allergenic extract injected into skin | 7,332 |
| Established patient office or other outpatient visit, 40-54 minutes | 8,565 |
| Blood test, lipids (cholesterol and triglycerides) | 8,728 |
| Hemoglobin a1c level | 9,965 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 10,083 |
| Blood test, comprehensive group of blood chemicals | 10,738 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 12,460 |
| Admn sarscov2 vacc 1 dose | 12,515 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 13,310 |
| Professional service for multiple injections of allergen | 14,436 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 16,399 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19,256 |
| Administration of influenza virus vaccine | 29,826 |
| Professional service for preparation and provision of 1 or more antigens | 34,554 |
| Insertion of needle into vein for collection of blood sample | 37,937 |
| Established patient office or other outpatient visit, 20-29 minutes | 42,945 |
| Established patient office or other outpatient visit, 30-39 minutes | 80,730 |
| Test for allergy using allergenic extract | 83,666 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).